As an independent and agile company, Calyx is investing in innovative technology, serving new markets, and delivering more value to help the global bio-pharmaceutical industry bring much-needed treatments to patients, faster.
At Calyx, we are committed to shaping the future of clinical research. Backed by the industry’s brightest minds and pioneering technology, we race toward the complex for the good of our customers and their patients around the world whose lives depend on the treatments we help them develop.
With a global footprint, robust operational infrastructure, and deep scientific knowledge, Calyx solves complex clinical development challenges to help our customers bring new medical treatments to patients who need them, faster.
Results that matter
Calyx’s proven solutions are used in the development of new medical treatments, enabling our customers to bring lifesaving and life-improving options to patients around the world.
To date, Calyx’s solutions have been used in the clinical development of over 650 approved medical treatments. We’re proud that over 70 of those are treatments that received Breakthrough Therapy designation and are now helping patients with serious conditions see substantial improvement, compared to other available therapies.
“At Calyx, we simply activate intelligence to improve lives around the world.”
– Stephen M. Bravo, MD, Chief Medical Officer, Calyx
Meet our leadership
Our leadership team is comprised of a diverse group of industry and technology veterans, whose experience in advancing life sciences is second to none.
Chief Financial Officer
Michael joined Calyx as Chief Financial Officer in April 2022, bringing a wealth of executive-level experience level in both operations and finance to the organization. Prior to joining Calyx, he worked primarily in IT-enabled service companies that provided support to US federal, state, and local governments as well as commercial entities in the US and internationally. Michael has a proven track record of helping private equity-backed, mid-market companies grow.
Chief Operating Officer
Jamie joined Calyx in January 2020 as the Chief Operating Officer bringing deep, global experience in driving operational excellence and breakthrough financial results. His 25 years’ experience includes a variety of operations, manufacturing, and senior executive roles across the aerospace, engineering, and professional services sectors. Jamie is a Chartered Engineer and holds an MBA from the University of Warwick Business School.
Chief Medical Officer
Stephen M. Bravo, MD
Stephen Bravo, MD joined Calyx in March 2021, bringing more than 30 years of broad scientific experience to the organization. His expertise stems from having served as a board-certified diagnostic radiologist at highly acclaimed healthcare centers, as a senior faculty member at leading academic institutions, and as a trusted scientific advisor to numerous global pharmaceutical companies. An acknowledged expert in Neuroradiology, Musculoskeletal Radiology, and Interventional Radiology, Dr. Bravo has authored numerous publications and abstracts, holds licenses in three states, and has undertaken the role of principal investigator in over 100 clinical trials.
Chief Strategy Officer
Michelle Ronan joined Calyx in April 2022, bringing expertise in developing and executing long-term strategic plans in the global eClinical market. She is an accomplished Head of Corporate Strategy and Development, with significant experience centred around private equity backed businesses, guiding teams through the different stages of a business’ lifecycle. Prior to joining Calyx, Michelle was part of the Executive Leadership team at Signant Health and CRF Health. Michelle is a Chartered Accountant and spent 15 years in M&A specialising in the Life Sciences sector.
Chief Commercial Officer
John Blakeley joined Calyx as Chief Commercial Officer in January 2020 and brings more than 30 years of senior commercial leadership experience. His expertise in the eClinical solutions space stems from having held C-suite positions at CRF Health, Greenphire, and ERT. John is a seasoned and innovative sales leader who has a successful track record in building high-performing teams to develop creative clinical solutions for customers and drive revenue growth.
General Counsel & Chief Compliance Officer
Purvesh Patel joined Calyx in November 2020 leading the Legal, Compliance, Quality, Information Security, Data Privacy and Corporate Development functions. He has nearly 20 years of in-house legal and international corporate transactions experience in highly regulated health and technology sectors. Purvesh has his JD from Case Western Reserve University School of Law and is a trusted business partner relied on by C-suite leaders and Boards to advise on strategic planning, managed growth and governance on a global scale.
Chief People Officer
Shelley Latham joined Calyx as Chief People Officer in January 2020 and brings 25 years of experience leading Human Resources across a broad range of organizations. Before joining Calyx, she served as CHRO at HealthTrust Europe LLP and held various senior positions leading HR functions and delivering strategic projects in healthcare and other sectors. Shelley is a Chartered Fellow of the Institute of Personnel Development and holds an MBA from Nottingham Business School.
Chief Digital and Information Officer
Richard Wallace joined Calyx as Chief Digital Information Officer in February 2021, bringing a wealth of experience from having established and implemented successful business and technology strategies across multiple organizations. Prior to joining Calyx, Richard was Global CIO of Kantar Media & Worldpanel (WPP Group) and has led several R&D transformation projects at IAG / British Airways, G4S & Santander. Richard holds a degree in Economics from the University of Newcastle and an Executive Diploma from the Saïd Business School, University of Oxford.
Meet the scientists
Extend the deep and diverse experience of Calyx’s highly tenured scientific experts to your own clinical development team.
Chief Scientific Officer
Peter Steiger, PhD
Vice President, Medical Imaging & Head of Oncology
Oliver Bohnsack, MD PhD MBA
Associate Director, Medical Imaging
Surabhi Bajpai, MD
Vice President, Medical Imaging
Manish Sharma, MD DMRE
Vice President, Scientific and Medical Services
Sally (Sarah) Warner, PhD, CCD
Director, Scientific & Medical Services
Manuela Lesch, RT
Director, Scientific & Medical Services
Farhan Syed, PhD
Where we are
“Think globally. Act locally.” – Patrick Geddes.
As clinical trials become increasingly complex and large-scale, involving many different regions worldwide, it’s critical to partner with someone whose global capabilities and infrastructure you can trust.
Join our team
Are you passionate about helping others? Do you want to work in a dynamic industry with pioneering technology?
Join our growing team and take advantage of the many benefits we offer. Contact us to learn how you can advance your career while making a difference for patients around the world.